NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday

Published 01/09/2022, 16:14
Updated 01/09/2022, 17:11
© Reuters.  Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday
IXIC
-
FIVE
-
NTNX
-

  • Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) jumped 48.5% to $19.90 after Novo Nordisk (CSE:NOVOb) announced it will acquire the company for $20 per share in cash.
  • GigaCloud Technology Inc. (NASDAQ: GCT) surged 45% to $21.20.
  • Shuttle Pharmaceuticals, Inc. (NASDAQ: SHPH) shares rose 30% to $50.02 amid post-IPO volatility. The company priced its IPO at $8.125 per unit.
  • Nutanix, Inc. (NASDAQ: NTNX) gained 29.8% to $22.45 after the company reported better-than-expected sales results for its fourth quarter and issued strong revenue forecast.
  • Golden Sun Education Group Limited (NASDAQ: GSUN) rose 14.6% to $38.77.
  • Turquoise Hill Resources Ltd. (NYSE: TRQ) rose 13.8% to $31.26. Rio Tinto (LON:RIO) Group announced plans to acquire full ownership of Turquoise Hill Resources for C$43 per share in cash.
  • Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) rose 12% to $28.56. Agios Pharmaceuticals, last month, reported better-than-expected Q2 EPS and sales results.
  • Clarus Corporation (NASDAQ: CLAR) gained 9.7% to $16.66. Clarus issued statement on recent stock volatility and Parallax's unauthorized purchases of common stock.
  • Waldencast plc (NASDAQ: WALD) rose 8.7% to $9.09. Waldencast, last month, posted Q2 sales of $77.10 million.
  • Belite Bio, Inc (NASDAQ: BLTE) rose 7.8% to $34.64. Belite Bio recently announced it has commenced enrollment for the US Phase 3 clinical trial of LBS-008 in patients with Stargardt Disease.
  • Five Below, Inc. (NASDAQ: FIVE) rose 6% to $135.51 after the company reported Q2 earnings results.
  • © 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    Read at Benzinga

    Read the original article on Benzinga

    Latest comments

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.